MedPath

Effects of Proprioceptive Focal Stimulation (EQUISTASI) on Freezing of Gait in Parkinson's Disease

Not Applicable
Terminated
Conditions
Freezing of Gait
Parkinson Disease
Interventions
Device: EQUISTASI
Registration Number
NCT03211260
Lead Sponsor
ASST Gaetano Pini-CTO
Brief Summary

Freezing of gait (FOG) is a common disabling condition in Parkinson's disease (PD), causes falls, and impairs quality of life. Therapeutic options for this symptom are limited and of limited efficacy. Besides, the pathophysiology has been not clarified yet. Proprioceptive sensitivity is likely to play a role and recent studies have reported that high-frequency microfocal vibratory stimulation exert a modulatory effect of proprioceptive reflex circuits and could be considered a valuable treatment strategy. However, evidence is not available. The present study was designed to collect preliminary evidence of efficacy of a vibrotactile device (Equistasi) for the treatment of FOG.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • Patient with Parkinson's Disease
  • Stable drug therapy response without any change in the 3 months before the study.
  • written informed consent
Exclusion Criteria
  • Hoehn-Yahr stage ≥ 4
  • Cognitive decline (Mini Mental State Examination <26)
  • Systemic illness involving the nervous system
  • Diabetes
  • Presence of cardiac pacemaker
  • Presence of deep brain stimulation
  • Presence of severe dysautonomia with marked hypotension
  • History or active neoplasia
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
EQUISTASIEQUISTASIEquistasi is a nanotechnology for proprioceptive focal stimulation. Every patient will receive four patches to be placed on both legs for 4 weeks.
Primary Outcome Measures
NameTimeMethod
Freezing of gait questionnaire severity4 weeks

Change in freezing of gait questionnaire score

Secondary Outcome Measures
NameTimeMethod
39-item Parkinson's Disease Questionnaire4 weeks

Change in quality of life measured using the 39-item Parkinson's Disease Questionnaire

Treatment continuation4 weeks

Likelihood that patients would continue taking the trial treatment as assessed by a self-rating scale

Falls4 weeks

Number of falls recorded during the intervention period

Gait and Falls Questionnaire (GFQ) score4 weeks

Change in the GFQ score

Trial Locations

Locations (1)

Centro Parkinson, ASST Gaetano Pini-CTO

🇮🇹

Milano, Italy

© Copyright 2025. All Rights Reserved by MedPath